NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/10/2026
Back to search
Official data from USPTO
JEMIQTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
02/11/2026
Trademark type
Word
Nice classes
5, 10
Filing date
07/14/2025
Registration date
02/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2026
Last transaction
02/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
65
Owner location
Valby, DK
Examiner
MATZINGER, AMY L
Law office
N90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
H. Lundbeck A/S
Representatives
Maren Perry KING & SPALDING LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Sanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ofgenerated from and affecting the central nervous system; pharmaceutical preparations and substances for the treatment of central nervous system disorders; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosisprevention and treatment of psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosisprevention and treatment of dementiaAlzheimer's diseasedepressionpsychosisanxietyLennox-Gastaut diseaseepilepsyDravet SyndromeDevelopmental and Epileptic Encephalopathy (DEE)alpha-synucleinopathiesMultiple System Atrophy (MSA)dementia with Lewy bodiesrapid eye movement (REM) sleep behavior syndromeporphyriaHuntington's diseaseinsomniaParkinson's diseasesclerosismultiple sclerosisschizophreniabipolar disordercancerpainmigraineheadacheHorton's headachetraumatic brain injurypost-traumatic brain injurydizzinessseizuresstrokecognitive impairmentcognitive disorders and diseasesmood disordersfallsmovement disorders and diseasestremoragitationmaniaaggressionautismmelancholiaObsessive Compulsive Disorder (OCD)Tourette's syndromerestlessnessakathisiafatiguesomnolencenauseaCushing's diseaseAdrenogenital syndrome (AGS)narcolepsyPost-Traumatic Stress Disorder (PTSD)Attention Deficit Hyperactivity Disorder (ADHD)Progressive Supranuclear Palsy (PSP)Thyroid Associated Orbitopathy (TAO)Graves OrbitopathyHashimoto's Thyroiditisalcoholism and addiction; diagnostic agents and preparations for medical purposes; chemical substances for diagnostic and medical purposeschemical reagents for medical usediagnostic chemical reagents for medical purposes; medical diagnostic reagents
Class 10
Medical apparatusinfusion and injection devices for administering drugs; Medical syringesintravenous bags sold empty for intravenous therapyintravenous (IV) feeding tubesintravenous (IV) infusion pumpsintravenous (IV) catheters; injection devices for administering drugssyringes and needles for injections and medical purposes; Apparatus and instruments for diagnostic purposesdosage management dispensers for administering medicinesincorporating downloadable and recorded software for medical information management for use in web-based physical and psychological examination and assessment of patients at a distance and at a clinic; Medical devices and instruments for use in the diagnosismedicine administrationmonitoringassessmentcontrol and examination of psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune disorders and diseases; integrated medical systems comprising of medical instruments for diagnostics and examination of patients and downloadable software for processing patient intake and communications and information managementall for use in the examination and assessment of patients and clients; integrated medical systems comprised of medical instruments for treating central nervous system diseases and disorders and psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune disorders and diseasesall for the purposes of managementmeasurementmonitoringevaluationcontrolcollectionstoragetransmission and examination of patient and client data and information; medical instrumentsdevices for delivery and administering of medicines in the nature of infusion and injection devices and infusion pumps for providing medication administering informationguidancemanagement
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/23/2025
PUBO
PUBLISHED FOR OPPOSITION
12/23/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/17/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/24/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/24/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/23/2025
GNRT
NON-FINAL ACTION E-MAILED
09/23/2025
CNRT
NON-FINAL ACTION WRITTEN
09/23/2025
DOCK
ASSIGNED TO EXAMINER
09/19/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/14/2025
MAFR
APPLICATION FILING RECEIPT MAILED
07/14/2025
NWAP
NEW APPLICATION ENTERED
07/14/2025
Continuous trademark protection
Get notified about every new filing that threatens JEMIQTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.